AD patients have abnormal levels of ribosomal RNAs (rRNA18S, rRNA28S), ribosomal proteins (rpS5, rpS6, rpS10, rpS13), initiation factors (eIF3eta), and elongation factors (eEF1A, eEF2), suggesting aberrant protein synthesis. This evidence concerns the gene RPS6 and Alzheimer disease.